Product
Irinotecan + 5-FU + Leucovorin
1 clinical trial
1 indication
Indication
Pancreatic adenocarcinomaClinical trial
A Randomized, Phase 3 Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment of Patients With Pancreatic AdenocarcinomaStatus: Completed, Estimated PCD: 2021-08-30